{"id":"clm_8F23955A5DC1","entity":"regeneron-pharmaceuticals","predicate":"quarterly_revenue","value":"90,032,000 United States dollar","value_json":{"fp":"Q2","fy":2010,"accn":"0001206774-10-001689","form":"10-Q","filed":"2010-07-28","period":"Q2 FY2010","concept":"us-gaap:Revenues"},"valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2010-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Regeneron Pharmaceuticals quarterly revenue: 90,032,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_8F23955A5DC1, https://asof.is/claim/clm_8F23955A5DC1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm.","url":"https://asof.is/claim/clm_8F23955A5DC1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_180A6BFB73AB","supersedes":[],"first_seen_at":"2026-11-08T17:08:47.537551+00:00","updated_at":"2026-11-08T17:08:55.512322+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-07-28"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}